Visiomed Group SA
PAR:ALVMG
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.1646
0.34
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one ALVMG stock under the Base Case scenario is 0.3843 EUR. Compared to the current market price of 0.1726 EUR, Visiomed Group SA is Undervalued by 55%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Visiomed Group SA
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for ALVMG cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Visiomed Group SA
Balance Sheet Decomposition
Visiomed Group SA
Current Assets | 5.3m |
Cash & Short-Term Investments | 3m |
Receivables | 2.3m |
Non-Current Assets | 31.3m |
Long-Term Investments | 1.2m |
PP&E | 5.2m |
Intangibles | 25m |
Current Liabilities | 3.1m |
Accounts Payable | 2.1m |
Accrued Liabilities | 827k |
Other Current Liabilities | 207k |
Non-Current Liabilities | 9.4m |
Long-Term Debt | 7.9m |
Other Non-Current Liabilities | 1.5m |
Earnings Waterfall
Visiomed Group SA
Revenue
|
13.7m
EUR
|
Cost of Revenue
|
-789k
EUR
|
Gross Profit
|
12.9m
EUR
|
Operating Expenses
|
-12.7m
EUR
|
Operating Income
|
230k
EUR
|
Other Expenses
|
672k
EUR
|
Net Income
|
902k
EUR
|
Free Cash Flow Analysis
Visiomed Group SA
EUR | |
Free Cash Flow | EUR |
ALVMG Profitability Score
Profitability Due Diligence
Visiomed Group SA's profitability score is 29/100. The higher the profitability score, the more profitable the company is.
Score
Visiomed Group SA's profitability score is 29/100. The higher the profitability score, the more profitable the company is.
ALVMG Solvency Score
Solvency Due Diligence
Visiomed Group SA's solvency score is 65/100. The higher the solvency score, the more solvent the company is.
Score
Visiomed Group SA's solvency score is 65/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ALVMG Price Targets Summary
Visiomed Group SA
According to Wall Street analysts, the average 1-year price target for ALVMG is 0.714 EUR with a low forecast of 0.707 EUR and a high forecast of 0.735 EUR.
Dividends
Current shareholder yield for ALVMG is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
ALVMG Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Visiomed Group SA engages in the development and distribution of healthcare products and services. The company is headquartered in Puteaux, Ile-De-France. The company went IPO on 2011-07-05. The firm is primarily engaged in the design, manufacture and marketing of medical electronics. The company develops and markets health products in the fields of medical and well-being self-diagnosis to provide non-drug prevention and treatment solutions. The firm's product portfolio comprises MyThermo, an infrared contact-less medical thermometer; MyTension, an automatic blood pressure and pulse monitors; MyOxy, a finger pulse oximeter; MyECG, a pocket electrodiogram; MyGluco, a blood sugar meter; My Coach, a health and fitness coach, and Epiderm, a telemedicine dermatology mobile application, among others. The firm serves pharmacies, health professionals, hospitals, clinics and retirement homes. The company also offers connected solutions and COVID devices such as deconfinement kits, masks, filter cushion, serological tests etc. The Company’s subsidiaries include ThermoFlash and BewellConnect.
Contact
IPO
Employees
Officers
The intrinsic value of one ALVMG stock under the Base Case scenario is 0.3843 EUR.
Compared to the current market price of 0.1726 EUR, Visiomed Group SA is Undervalued by 55%.